J. Watson et al., 5-HT1A receptor agonist-antagonist binding affinity difference as a measure of intrinsic activity in recombinant and native tissue systems, BR J PHARM, 130(5), 2000, pp. 1108-1114
1 It has been reported that radiolabelled agonist:antagonist binding affini
ty ratios can predict functional efficacy at several different receptors. T
his study investigates whether this prediction is true for recombinant and
native tissue 5-HT1A receptors.
2 Saturation studies using [H-3]-8-OH-DPAT and [H-3]-MPPF revealed a single
, high affinity site (K(D)similar to 1 nM) in HEK293 cells expressing human
5-HT1A receptors and rat cortex. In recombinant cells, [H-3]-MPPF labelled
3-4 fold more sites than [H-3]-8-OH-DPAT suggesting the presence of more t
han one affinity state of the receptor. [H-3]-Spiperone labelled a single,
lower affinity site in HEK293 cells expressing h5-HT1A receptors but did no
t bind to native tissue 5-HT1A receptors. These data suggest that, in trans
fected HEK293 cells, human 5-HT1A receptors exist in different affinity sta
tes but in native rat cortical tissue the majority of receptors appear to e
xist in the high agonist affinity state.
3 Receptor agonists inhibited [H-3]-MPPF binding from recombinant 5-HT1A re
ceptors in a biphasic manner, whereas antagonists and partial agonists gave
monophasic inhibition curves. All compounds displaced [H-3]-8-OH-DPAT and
[H-3]-spiperone binding in a monophasic manner. In rat cortex, all compound
s displaced [H-3]-MPPF and [H-3]-8-On-DPAT in a monophasic manner.
4 Functional evaluation of compounds, using [S-35]-GTP gamma S binding, pro
duced a range of intrinsic activities from full agonism, displayed by 5-HT
and 5-CT to inverse agonism displayed by spiperone.
5 [H-3]-8-OH-DPAT: [H-3]-MPPF pK(i) difference correlated well with functio
nal intrinsic activity (r = 0.86) as did [H-3]-8-OH-DPAT:[H-3]-spiperone pK
(i) difference with functional intrinsic activity (r = 0.96).
6 Thus agonist:antagonist binding affinity differences may be used to predi
ct functional efficacy at human 5-HT1A receptors expressed in HEK293 cells
where both high and low agonist affinity stales are present but not at nati
ve rat cortical 5-HT1A receptors in which only the high agonist affinity st
ate was detectable.